Cell Source Inc (CLCS) 0.9500 $CLCS Cell Source

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cell Source Inc (CLCS) 0.9500 $CLCS

Cell Source Improving Immunotherapy with T-Cell Twist
ACCESSWIRE - Tue Apr 26, 7:00AM CDT
NEW YORK, NY / ACCESSWIRE / April 26, 2016 / Immunotherapy is undoubtedly one of the most talked about and promising areas in biotechnology today. As the library of research continues to grow, combination therapies are emerging to hopefully deliver more clinically meaningful outcomes. This is exemplified by the recent pact between Kite Pharma (NASDAQ: KITE) and Roche's (OTCQX: RHHBY) Genentech to collaborate (http://ir.kitepharma.com/releasedetail.cfm?ReleaseID=961129) on using Kite's experimental CAR-T (chimeric antigen-receptor T cell) treatment, KTE-C19, in combination with Roche's PD-L1 (programmed death ligand-1) immunotherapy, atezolizumab, in patients suffering from refractory, aggressive non-Hodgkin lymphoma (NHL).
KITE: 50.95 (+0.95), AMGN: 154.28 (+2.13), TEVA: 50.05 (-0.18)

Cell Source to Present at the LD Micro Main Event
Marketwired - Fri Nov 27, 8:34AM CST
Cell Source, Inc. (OTCQB: CLCS), a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced that it will be presenting at the 8th annual LD Micro Main Event on Thursday, December 3rd at 4PM PST. Itamar Shimrat (CEO of Cell Source) will be giving the presentation and meeting with investors.

Cell Source's Megadose Drug Combination Treats First Patient
Marketwire Canada - Wed Nov 11, 7:51AM CST
Cell Source, Inc. (OTCQB: CLCS) a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced today initial indications that its Megadose Drug Combination has been used to successfully treat a cancer patient in Italy. Cell Source's proprietary Megadose Drug Combination (licensed exclusively from the Weizmann Institute of Science in Israel) is expected to increase bone marrow transplantation (BMT) success and survival.

Inaugural Scientific Advisory Board Summit JV Pharma Collaboration Initiative
Marketwired - Wed Nov 04, 8:14AM CST
Cell Source, Inc. (OTCQB: CLCS) a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced their initiative for joint venture Pharma collaborations at their inaugural Scientific Advisory Board (SAB) Summit held in New York City. SAB members are leading experts from Harvard University, Stanford University, Oxford University, Mt. Sinai Medical and University Hospital Wurzburg. They have endorsed Cell Source's pursuit of JV collaborations with major Pharma players. Recent scientific developments and new provisional patent applications have set the stage for these JV Pharma Collaborations to leverage Cell Source's Veto Cell technology and accelerate its commercialization.

Cell Source names Dr Dennis Brown as board chairman
M2 - Thu Aug 20, 3:52AM CDT
Biotechnology company Cell Source(OTC BB:CLCS) reported on Wednesday it has appointed Dr Dennis Brown as the chairman of its board of directors.

Cell Source Appoints Dr. Dennis Brown as Chairman of Its Board of Directors
Marketwired - Wed Aug 19, 8:04AM CDT
Cell Source, Inc. (OTCQB: CLCS), a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced today that Dr. Dennis Brown, currently a Director of Cell Source, has been appointed Chairman of the Board of Directors.

Cell Source Appoints Dr. Robert Negrin to Its Scientific Advisory Board
Marketwired - Mon Jul 06, 7:31AM CDT
Cell Source, Inc. (OTCQB: CLCS) a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced today that Dr. Robert S. Negrin, Director of the Bone and Marrow Transplantation Division and Professor of Medicine at Stanford University, has joined its Scientific Advisory Board.

Cell Source Appoints Dr. Steven Burakoff to Its Scientific Advisory Board
Marketwired - Mon Jun 29, 7:30AM CDT
Cell Source, Inc. (OTCQB: CLCS), a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced today that Dr. Steven Burakoff, Director of the Tisch Cancer Institute at Mount Sinai Medical Center and Professor of Cancer Medicine and Hematology and Medical Oncology at the Icahn School of Medicine at Mount Sinai, has joined its Scientific Advisory Board.

World Class Immunologist Dr. Herman Waldmann Joins Cell Source's Scientific Advisory Board
Marketwired - Wed Jun 17, 7:31AM CDT
Cell Source, Inc. (OTCQB: CLCS) a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced today that Dr. Herman Waldman, who served as Department Head and Professor Emeritus of Pathology at the Oxford Medical School and Clinical Director of Oxford's Therapeutic Antibody Centre, has joined the Cell Source Scientific Advisory Board.

Cell Source names Dr Terry Strom as SAB chair
M2 - Fri Jun 05, 4:52AM CDT
Biotechnology company Cell Source (OTCBB:CLCS) revealed on Thursday the addition of Dr Terry Strom as chairman of its Scientific Advisory Board (SAB).

Cell Source Appoints Dr. Terry Strom as Chairman of Its Scientific Advisory Board
Marketwired - Thu Jun 04, 10:22AM CDT
Cell Source, Inc. (OTCQB: CLCS) a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced today that Dr. Terry Strom, Professor of Medicine and Surgery at Harvard Medical School and Director of The Transplant Institute at Beth Israel Deaconess Medical Center, has been retained to serve as Chairman of its Scientific Advisory Board.

Cell Source to Present at the 2015 Marcum MicroCap Conference
Marketwired - Fri May 22, 1:01PM CDT
Cell Source, Inc. (OTCQB: CLCS), a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced today that it will present at the 2015 Marcum MicroCap Conference on Thursday, May 28th, 2015 in New York City at the Grand Hyatt Hotel.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 187

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 394

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 182

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 233

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 238

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 183

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 154

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Kinross Lawsuit Puts Round Mountain Claims Under Fire

Updated Category News Views 128

A mine can swallow a rosy forecast faster than any spreadsheet admits. That is the ugly center of the proposed securities class action involving Kinross Gold: not merely that production guidance came down, but the allegation that investors were sold too much confidence before the operational reality at Round Mountain Phase S surfaced. NYSE:KGC dropped from $27.62 on...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 168

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 217

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading

Top 5 Most Recently Viewed Articles

Kipu Health Strengthens Behavioral Health with Hatch Compliance Deal

Updated Category News Views 184

Kipu Health Expands Its Portfolio with a Strategic Acquisition Kipu Health is making a significant advancement in the behavioral health sector by acquiring Hatch Compliance. This merger brings in cutting-edge compliance management systems specifically designed for behavioral health organizations. Boosting Operational Efficiency for Behavioral Health Organizations As a...

Continue Reading
Exploring the Future of Autonomous Economy with Lav and Magma

Updated Category News Views 245

Understanding the Autonomous Economy Lava Network and Magma Devs, in collaboration with Google Cloud, are set to delve into the transformative concept of the autonomous economy. This ambitious initiative aims to showcase how artificial intelligence (AI) agents and stablecoins are revolutionizing digital commerce. The exciting event will bring together industry leaders to...

Continue Reading
Micross Expands with AEMtec Acquisition: European Growth

Updated Category News Views 68

Micross Advances into Europe with AEMtec Acquisition Here's the scoop: Micross Components, a heavyweight in microelectronics, just sealed a deal to acquire AEMtec GmbH. This acquisition isn't just peanuts—it's a big leap forward for Micross, broadening its European presence and bolstering its advanced packaging and optoelectronics game. You'd think these folks mean...

Continue Reading
Innovative Vanpool Program Revolutionizes Student Transportation

Updated Category News Views 128

Transforming Student Transportation with Vanpool Systems Augusta County Public Schools has taken a significant step in improving student transportation through an innovative vanpool program. Collaborating with Secure Solar Futures, this program focuses on utilizing plug-in electric vans, greatly enhancing the transportation experience for students. How the Vanpool Program...

Continue Reading
Understanding Market Sentiments Surrounding XPO Logistics

Updated Category News Views 131

XPO's Short Interest Overview XPO's short percent of float has declined by 10.67% since the last report, with a current tally of 5.26 million shares sold short. This accounts for 5.19% of the overall shares available for trading. On average, it would take approximately 3.87 days for traders to cover their short positions based on the recent trading volumes. Importance of...

Continue Reading